50% of physicians are satisfied with access to patient information

Roughly half of physicians are very or extremely satisfied with their access to patient information, according to a survey conducted by Surescripts.

Surescripts partnered with ORC International in conducting the survey, which included the responses from 300 primary care physicians. The survey aimed to provide insight into physician access and need for patient data.

Key findings included:

  • 50 percent of physicians were very or extremely satisfied with their access to patient information.
  • 83 percent of physicians believed access to medication adherence information is a high priority, but only 17 percent can retrieve that information electronically.
  • 56 percent of physician reported they did not trust information they can access about medication adherence, making it the least reliable information type. Distrust in adherence data stems from it being provided by patients, who can forget or misreport crucial information.
  • 29 percent of physicians reported medical history information as untrustworthy, followed by drug formulary coverage (29 percent), medication cost (29 percent) and medication history (28 percent).
  • 56 percent of physicians reported out-of-pocket cost of medication is a high priority, but only 11 percent could access electronically.
  • 74 percent of physicians believed it is important to consider a patient’s medical benefit information before prescribing.
  • 59 percent of physicians wanted to be able to compare the cost of similar medications.
  • 88 percent of physicians believed information about other care their patients had received is a priority, but only 30 percent have easy access to it.
  • 33 percent of physicians believed they can easily determine which other care providers a patient has seen.
  • 30 percent pf physicians reported having a secure, electronic way to communicate with other providers.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.